D'AMICO, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 20.312
EU - Europa 10.070
AS - Asia 3.001
SA - Sud America 518
OC - Oceania 81
AF - Africa 65
Continente sconosciuto - Info sul continente non disponibili 11
Totale 34.058
Nazione #
US - Stati Uniti d'America 20.075
GB - Regno Unito 3.741
IT - Italia 2.281
SE - Svezia 1.133
CN - Cina 1.062
DE - Germania 708
HK - Hong Kong 650
UA - Ucraina 438
IE - Irlanda 331
SG - Singapore 323
TR - Turchia 301
FI - Finlandia 300
ES - Italia 238
BG - Bulgaria 227
FR - Francia 227
IN - India 135
PE - Perù 135
CA - Canada 123
CO - Colombia 114
ID - Indonesia 108
BR - Brasile 104
MX - Messico 89
IR - Iran 79
NL - Olanda 78
AU - Australia 72
KR - Corea 66
CL - Cile 64
VN - Vietnam 64
BE - Belgio 62
EC - Ecuador 62
MY - Malesia 56
RU - Federazione Russa 53
PT - Portogallo 41
CZ - Repubblica Ceca 32
JP - Giappone 32
CH - Svizzera 29
LT - Lituania 28
AR - Argentina 27
RO - Romania 24
PH - Filippine 19
NO - Norvegia 17
TW - Taiwan 16
PK - Pakistan 14
SA - Arabia Saudita 14
ZA - Sudafrica 14
GR - Grecia 13
BD - Bangladesh 11
EG - Egitto 10
HU - Ungheria 10
NG - Nigeria 10
IL - Israele 9
IQ - Iraq 9
MK - Macedonia 9
NZ - Nuova Zelanda 9
PL - Polonia 9
PR - Porto Rico 9
DK - Danimarca 8
AT - Austria 7
AL - Albania 6
BO - Bolivia 6
BZ - Belize 6
RS - Serbia 6
TH - Thailandia 6
GH - Ghana 5
VE - Venezuela 5
EU - Europa 4
KE - Kenya 4
OM - Oman 4
SI - Slovenia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BF - Burkina Faso 3
CD - Congo 3
CU - Cuba 3
CY - Cipro 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
LB - Libano 3
MA - Marocco 3
MO - Macao, regione amministrativa speciale della Cina 3
SY - Repubblica araba siriana 3
A1 - Anonimo 2
AE - Emirati Arabi Uniti 2
BJ - Benin 2
DZ - Algeria 2
HR - Croazia 2
LK - Sri Lanka 2
LY - Libia 2
PA - Panama 2
AD - Andorra 1
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
AW - Aruba 1
BY - Bielorussia 1
EE - Estonia 1
GP - Guadalupe 1
JO - Giordania 1
KW - Kuwait 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
Totale 34.046
Città #
Fairfield 3.192
Southend 2.655
Woodbridge 1.931
Houston 1.763
Ashburn 1.594
Chandler 1.579
Seattle 1.162
Cambridge 1.034
Wilmington 983
Ann Arbor 918
Jacksonville 909
Nyköping 855
Dearborn 824
Hong Kong 621
Beijing 476
Modena 449
San Diego 337
Dublin 319
Princeton 255
New York 239
Sofia 227
Singapore 199
Eugene 174
Milan 158
Helsinki 150
Izmir 144
London 118
Bologna 97
Rome 97
Bremen 93
Lima 90
Jakarta 87
Redwood City 80
Shanghai 80
Boardman 74
Des Moines 72
Fremont 71
Norwalk 62
Brussels 56
Ottawa 53
Dong Ket 50
Falls Church 49
Madrid 38
Parma 38
Quito 35
Reggio Emilia 35
Kilburn 33
Hefei 32
Bogotá 31
Frankfurt am Main 28
San Jose 28
Santiago 28
Chicago 27
Nanjing 27
Turin 27
Los Angeles 26
Medellín 26
San Francisco 26
Sydney 24
Grafing 23
Seongnam 23
Guangzhou 22
Naples 21
Phoenix 21
Verona 21
Florence 20
Groningen 20
Paris 20
Munich 19
Trujillo 19
Toronto 18
Leawood 17
Bari 16
Mountain View 16
Perugia 16
San Mateo 16
Chiswick 15
Dongguan 15
Fort Worth 15
Hounslow 15
Padova 15
Perozinho 15
Prescot 15
Seoul 15
Valencia 15
Brno 14
Kunming 14
Guayaquil 13
Indiana 13
Barcelona 12
Central 12
Genoa 12
Piacenza 12
Rimini 12
San Giuliano Milanese 12
Santiago de Cali 12
Shenyang 12
Vicenza 12
Amsterdam 11
Saint Petersburg 11
Totale 25.532
Nome #
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement 1.567
VALORE PROGNOSTICO E PREDITTIVO DI p53 NEL CARCINOMA MAMMARIO TRATTATO CON CHEMIOTERAPIA NEOADIUVANTE 564
Correlation Between Immune-related Adverse Event (IRAE) Occurrence and Clinical Outcome in Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Nivolumab: IRAENE Trial, an Italian Multi-institutional Retrospective Study 507
Evaluating non-randomised intervention studies 447
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 348
Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis 307
GD2 expression in breast cancer. 285
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management 278
Non-steroid agents for idiopathic pulmonary fibrosis 267
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 259
Pectoralis Muscle Transposition in Association with the Ravitch Procedure in the Management of Severe Pectus Excavatum. 252
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial . 241
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study. 238
A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical score 227
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study 226
Prenatal education for congenital toxoplasmosis 223
Up-regulation of the canonical Wnt-3A and Sonic hedgehog signaling underlies melanocortin-induced neurogenesis after cerebral ischemia 216
Magnetic Resonance Imaging and Ultrasonography in Predicting Infiltrating Residual Disease after Preoperative Chemotherapy in Stage II-III Breast Cancer 208
Effect of expert-patient teaching on empathy in nursing students: a randomized controlled trial 208
Analgesia during abdominal aortic aneurysm endovascular repair: remifentanil vs fentanyl-midazolam - a randomized controlled trial 204
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 202
Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV 197
Home care for heart failure: can caregiver education prevent hospital admissions? A randomized trial in primary care 197
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: Results of the phase III multicentric Italian study Short-HER 196
Nonalcoholic Fatty Liver Disease in HIV-Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors 196
Breathlessness, but not cough, suggests chronic obstructive pulmonary disease in elderly smokers with stable heart failure 195
Novel genetic association of TNF-α-238 and PDCD1-7209 polymorphisms with long-term non-progressive HIV-1 infection. 194
CD4+ T-cell differentiation, regulatory T cells and gag-specific T lymphocytes are unaffected by CD4-guided treatment interruption and therapy resumption. 194
Decreased mitochondrial DNA content in subcutaneous fat from HIV-infected women taking antiretroviral therapy as measured at delivery. 193
Antibiotic Prophylaxis to Reduce Respiratory Tract Infections and Mortality in Adults Receiving Intensive Care 193
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 192
Selenium for preventing cancer 191
Prevalence and Risk Factors of PTSD in Children and Adolescents after the 2012 Earthquake in the Emilia Romagna Region: implications for intervention 191
Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with Clinically Isolated Syndrome. 190
Short-term and long-term effects of tibolone in postmenopausal women 189
A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy. 189
Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer.. 188
Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy. 188
Correlating tumor-infiltrating lymphocytes and lung cancer stem cells: a cross-sectional study. 188
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 187
Are parents of children hospitalized with severe community-acquired pneumonia more satisfied with care when physicians allow them to share decisions on the antibiotic route? 187
GREASE II. A phase II randomized, 12-month, parallel-group, superiority study to evaluate the efficacy of a Modified Atkins Diet in Autosomal Dominant Polycystic Kidney Disease patients 187
Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis 184
Prognostic value of diffusion-weighted imaging summation scores or apparent diffusion coefficient maps in newborns with hypoxic-ischemic encephalopathy 183
Predictive and prognostic role of p53 according to tumor phenotype in breast cancer patients treated with preoperative chemotherapy: a single-institution analysis 183
Prevalence and risk factors of Post-Traumatic Stress Disorder in children and adolescents after the 2012 earthquake affecting the Emilia Romagna Region (Italy). 183
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer. 183
Cancer stem-neuroendocrine cells in an atypical carcinoid case report. 182
Predictive Value of Intracellular HIV-1 DNA Levels During CD4-Guided Treatment Interruption in HIV(+) Patients 181
Role Of The QFT-IT Assay For The Diagnosis Of Latent Tuberculosis Infection Among Adult Immigrants 181
Final results of a phase II randomized trial of neoadjuvant anthracycline-taxane chemotherapy plus lapatinib, trastuzumab, or both in HER2-positive breast cancer (CHER-LOB trial). 181
The effect of potassium supplementation on blood pressure in hypertensive subjects: A systematic review and meta-analysis. 181
Major discrepancies between what clinical trial registries record and paediatric randomised controlled trials publish 181
Gallstone disease in non-alcoholic fatty liver: Prevalence and associated factors 178
Discordances originated by multiple meta-analyses on interventions for myocardial infarction: a systematic review 178
Cancer Stem-Like Cells in a Case of an Inflammatory Myofibroblastic Tumor of the Lung. 178
Overall survival in patients with lung adenocarcinoma harboring "niche" mutations: an observational study 175
Use of adjunctive cardiovascular therapy in patients hospitalized for acute exacerbations of COPD. 173
Pain and emotional distress in leukemia patients at diagnosis. 172
One model, several results: the paradox of the Hosmer-Lemeshow goodness-of-fit test for the logistic regression model 171
Systematic review of maternal voice interventions demonstrates increased stability in preterm infants 171
Short-Term Efficacy of Upper-Extremity Exercise Training in Patients With Chronic Airway Obstruction: A Systematic Review. 171
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 170
Double-blind, placebo-controlled, multicentric randomized phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal HER2-negative, hormone receptor-positive operable breast cancer 170
Amantadine for fatigue in multiple sclerosis 170
Anti-Müllerian hormone-based prediction model for a live birth in assisted reproduction 169
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration 169
Commentary: The debate on non-inferiority trials: ' when meta-analysis alone is not helpful' 168
Chronic total coronary occlusion in patients with intermediate viability: value of low-dose dobutamine and contrast-enhanced 3-T MRI in predicting functional recovery in patients undergoing percutaneous revascularisation with drug-eluting stent. 168
Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave Dreams Study (Brain Venous Drainage Exploited Against Multiple Sclerosis): study protocol for a randomized controlled trial. 166
Cyclophosphamide for multiple sclerosis 165
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 165
Clinical differences in sarcoidosis patients with and without lymphoma: a single-center retrospective cohort analysis. 165
Trastuzumab containing regimens for early breast cancer. 164
Streptococcus salivarius by nasal spray for recurrent otitis: how good is the evidence? 163
Antibiotics for preventing respiratory tract infections in adults receiving intensive care 163
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 163
Early inspiratory effort assessment by esophageal manometry early predicts noninvasive ventilation outcome in de novo respiratory failure: a pilot study. 163
Facioscapulohumeral muscular dystrophy: new insights from compound heterozygotes and implication for prenatal genetic counselling. 163
Risk of severe cardiotoxicity following treatment with trastuzumab: a meta-analysis of randomized and cohort studies of 29,000 women with breast cancer 163
3* Final analysis of the phase III multicentric Italian study Short-HER: 9 weeks vs 1 year adjuvant trastuzumab for HER2+ early breast cancer 162
Antithrombin plasma levels decrease is associated with preeclampsia worsening. 161
Trastuzumab-containing regimens for metastatic breast cancer 161
Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy 161
Motor and Postural Patterns Concomitant with General Movements Are Associated with Cerebral Palsy at Term and Fidgety Age in Preterm Infants 159
Isolation and Identification of Cancer Stem-Like Cells in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Pilot Study 159
A prognostic model based on nodal status and Ki 67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy 158
Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): A structured summary of a study protocol 157
The diagnostic reliability of urinary cytology: A retrospective study. 155
Antibiotic prophylaxis in intensive care units: meta-analyses versus clinical practice 155
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 155
Selenium for preventing cancer. 154
Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer 153
Does needle calibre affect pain and complication rates in patients undergoing transperineal prostate biopsy? A prospective, randomized trial 151
Antibiotic prophylaxis to prevent nosocomial infections in patients in intensive care units: evidence that struggle to convince practising clinicians 150
Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care 149
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 149
Indirect comparisons of competing interventions 148
Preoperative chemotherapy plus trastuzumab, lapatinib or both in HER2 positive operable breast cancer: results of the randomized phase II CHER-LOB study 148
ALDH Expression in Angiosarcoma of the Lung: A Potential Marker of Aggressiveness? 147
Totale 20.945
Categoria #
all - tutte 145.571
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 145.571


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.629 526 250 189 390 759 1.159 1.103 730 621 275 366 261
2020/20216.280 457 253 568 566 847 510 419 714 351 705 589 301
2021/20224.950 348 538 447 213 123 276 282 250 534 440 912 587
2022/20236.535 658 666 418 496 614 698 189 551 949 653 324 319
2023/20244.286 271 281 278 366 631 493 477 550 126 162 228 423
2024/2025225 225 0 0 0 0 0 0 0 0 0 0 0
Totale 34.508